Suchergebnisse - "Ernst, Matthew S"

PubPharm (8)

1

Outcomes of Patients with Brain Metastases from Renal Cell Carcinoma Receiving First-line Therapies : Results from the International Metastatic Renal Cell Carcinoma Database Consortium

enthalten in: European urology | 2024

von Takemura, K. | Lemelin, A. | Ernst, M. | +21

2

Characterization of Patients with Metastatic Renal Cell Carcinoma Undergoing Deferred, Upfront, or No Cytoreductive Nephrectomy in the Era of Combination Immunotherapy : Results from the International Metastatic Renal Cell Carcinoma Database Consortium

enthalten in: European urology oncology | 2023

von Takemura, K. | Ernst, M. | Navani, V. | +17

3

Prognostic Models in Metastatic Renal Cell Carcinoma

enthalten in: Hematology/oncology clinics of North America | 2023

von Lemelin, A. | Takemura, K. | Heng, D. | +1

4

Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma

enthalten in: European urology | 2023

von Ernst, M. | Navani, V. | Wells, J. | +17

ErratumIn: Eur Urol. 2023 Jun;83(6):e166-e167. - PMID 36967358

5

Reply to Binghao Zhao, Hao Xing, and Wenbin Ma's Letter to the Editor re : Matthew S. Ernst, Vishal Navani, J. Connor Wells, et al. Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma. Eur Urol. 2023;84:109-116

enthalten in: European urology | 2023

von Ernst, M. | Heng, D.

CommentOn: Eur Urol. 2023 Jul;84(1):109-116. - PMID 36707357

6

Corrigendum to "Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma" [Eur Urol 2023

enthalten in: European urology | 2023

von Ernst, M. | Navani, V. | Wells, J. | +17

ErratumFor: Eur Urol. 2023 Jan 25;:. - PMID 36707357

7

Characterization of Patients With Metastatic Renal Cell Carcinoma Experiencing Complete Response to First-line Therapies : Results From the International Metastatic Renal Cell Carcinoma Database Consortium

enthalten in: The Journal of urology | 2023

von Takemura, K. | Navani, V. | Ernst, M. | +17

CommentIn: J Urol. 2023 Apr;209(4):709. - PMID 36700384

8

TRK Inhibition with Entrectinib in Metastatic Salivary Secretory Carcinoma (SC) : A Case Report

enthalten in: Current oncology (Toronto, Ont.) | 2022

von Ernst, M. | Lysack, J. | Hyrcza, M. | +2

1
[1]